GTA glyceryl triacetate ( DrugBank: Glyceryl triacetate )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 307 | Canavan disease | 1 |
307. Canavan disease
Clinical trials : 6 / Drugs : 11 - (DrugBank : 5) / Drug target genes : 2 - Drug target pathways : 2
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00724802 (ClinicalTrials.gov) | March 2008 | 18/6/2008 | Oral Glyceryl Triacetate (GTA) in Newborns With Canavan | Oral Glyceryl Triacetate (GTA) in Newborns With Canavan | Canavan Disease | Dietary Supplement: GTA (Glyceryl triacetate);Drug: GTA glyceryl triacetate | Shaare Zedek Medical Center | NULL | Recruiting | N/A | 18 Months | Both | 1 | N/A | Israel |